18
Participants
Start Date
March 16, 2023
Primary Completion Date
August 31, 2025
Study Completion Date
December 31, 2025
fractionated busulfan-based conditioning regimen
"Drug: Chidamide 30 mg oral twice weekly for 2 weeks Drug: Fludarabine 35 mg/m2 intravenously daily for 5 days in the 2nd week Drug: Cytarabine~1 g/m2 intravenously for 5 days in the 2nd week Drug: Busulfan 3.2 mg/kg intravenously daily for 2 days in the 1st week, 1.6 mg/kg intravenously daily for 4 days in the 2nd week Procedure/Surgery: allogeneic hematopoietic stem cell transplantation"
RECRUITING
West China Hospital, Sichuan University, Chengdu
Sichuan University
OTHER